Bausch + Lomb wins FDA approval; Ariosa expands prenatal Dx;

 @FierceMedDev: German cops seize Boston Scientific stents in cutthroat patent fight. More | Follow @FierceMedDev

 @MarkHFierce: It's that time of year again: We're seeking nominations for this year's fiercest medical device and Dx companies. Item | Follow @MarkHFierce

 @DamianFierce: Medtronic rode some international sales success to quarterly revenue growth. Article | Follow @DamianFierce

> Bausch + Lomb gained an FDA signoff for a new posterior chamber intraocular lens designed, in part, to correct for astigmatism. Release

> Allegheny General Hospital researchers in Pittsburgh are testing a new dissolvable coronary stent. Story

> Hologic ($HOLX) won FDA approval for 2-D imaging software designed for mammography screenings. Item

> Covidien ($COV) says its new bronchoscopy diagnostic system has been included in the new American College of Chest Physicians guidelines to help diagnose and manage lung cancer. Release

> Cancer Genetics ($CGIX) has signed on with MultiPlan, and the company will market Cancer Genetics' diagnostic tests to its network of more than 900,000 healthcare providers in the U.S. News

> ALung Technologies will work with Curative Medical to pursue regulatory approval in China for its Hemolung Respiratory Assist System. Release

> Ariosa Diagnostics has expanded its Harmony prenatal test to include twin pregnancies naturally conceived or conceived using the patient's own egg. More

Biotech News

 @FierceBiotech: New special: Top 10 Biotech CEO Pay Packages of 2012 via @RyanMFierce and @EmilyMFierce. Report | Follow @FierceBiotech

 @JohnCFierce: Bayer bolsters campaign for PAH drug riociguat with positive long-term data. More | Follow @JohnCFierce

 @RyanMFierce: Interviewed Regeneron's Yancopoulos, biotech's highest paid exec in 2012, about promising allergy drug and success recipe. Story | Follow @RyanMFierce

> Novo nabs anti-infectives outfit in $700M buyout. More

> Pfizer picks up the pieces after its armed antibody crashes in PhIII. Article

> Analysts question Teva's blockbuster expectations on drug makeovers. Story

Pharma News

 @FiercePharma: ICYMI: 20 Highest-Paid Biopharma CEOs of 2012. Feature Reactions? Use #FPexecpay. | Follow @FiercePharma

 @EricPFierce: Women sue Apotex over manufacturing issues that led to too many placebos and unexpected pregnancies. More | Follow @EricPFierce

> Warner Chilcott CEO up for $9.2M handshake after Actavis deal. News

> Novo A/S snatches up antibacterials-maker Xellia as part of new investment strategy. Article

> Will U.K. watchdogs change their minds on Avastin in ovarian cancer? More

Biotech Research News

 @EmilyMFierce:  | Follow @EmilyMFierce

> Researchers pinpoint protein involved in cancer cell death. Item

> Alnylam reports positive preclinical results for RNAi therapy to treat rare metabolic disease. More

> Drug boosts effectiveness of radiation therapy for brain tumors. Story

> Scientists use cloning method to create embryonic stem cells. Article

Pharma Manufacturing News

> Novartis' Sandoz unit recalls products from U.S., Poland. News

> Chinese drugmaker fights counterfeiting in Africa with SMS technology. More

> Impax brings in big guns to get on top of manufacturing problems. Story

> Apotex sued over problems on contraceptive packaging line. Article

> Gorsky pleads with employees to think quality. More

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.